From Scientific Promise to Commercial Reality: How Should the Industry Prioritise the Next Generation of Radioligand Therapy Opportunities?
4:00 pm - Thursday 3rd December 2026
- Evaluating which targets, indications and development strategies are most likely to translate into clinically impactful and commercially successful radioligand therapies
- Understanding how leading organisations assess emerging opportunities and differentiate between promising innovation and crowded market segments
- Exploring how competitive intelligence, early clinical data and evolving market dynamics can be leveraged to inform portfolio and investment decisions